Sodium channel inhibitors, like those targeting SCN5A, may help curb metastasis, while calcium channels (e.g., SPCA1 and PMCA2) inhibitors are implicated in the proliferation of basal-like and HER2-positive BC subtypes (Lastraioli et al., 2015). This evidence concerns the gene SCN5A and breast cancer.